Trial Profile
A Randomized, Double-Blind, Trial Comparing the Efficacy of Linaclotide to Senna in Relieving Symptoms in Patients With Chronic Idiopathic Constipation (CIC)
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Jul 2019
Price :
$35
*
At a glance
- Drugs Linaclotide (Primary) ; Senna-alexandrina
- Indications Constipation
- Focus Therapeutic Use
- 12 Jun 2019 Status changed to discontinued.
- 20 Oct 2015 Planned End Date changed from 1 Dec 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.
- 20 Oct 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.